Schedule 13D ownership disclosure

LIPELLA PHARMACEUTICALS INC.

Common Stock, par value $0.0001 per share · CUSIP: 53630L209

Event date: 2025-04-07

Filing-level shares
209,641.00
Percent of class
4.8%
  • Michael B. ChancellorReported CIK 0001959360

    Shares: 209,641.00 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-25-000612
Form type
SCHEDULE 13D/A
Filer
Chancellor Michael B
CIK
CIK 1959360
Filed
Apr 09, 2025
Reporting period
Apr 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub